Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ligand Pharmaceuticals

108.07
-0.4800-0.44%
Post-market: 108.070.00000.00%19:41 EDT
Volume:102.96K
Turnover:11.00M
Market Cap:2.08B
PE:-490.23
High:108.34
Open:106.95
Low:104.65
Close:108.55
Loading ...

Ligand to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswire
·
24 Apr

LGND: Pelthos To Become Public Company

Zacks Small Cap Research
·
23 Apr

Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings

Benzinga
·
18 Apr

Dow Falls Over 1%; US Initial Jobless Claims Decline

Benzinga
·
17 Apr

Ligand to Combine Pelthos Unit With Channel Therapeutics

Dow Jones
·
17 Apr

Ligand Pharmaceuticals to Merge Units With Channel Therapeutics to Launch Pelthos Therapeutics

MT Newswires Live
·
17 Apr

BRIEF-Ligand Subsidiary Pelthos Therapeutics To Combine With Channel Therapeutics

Reuters
·
17 Apr

Ligand Subsidiary Pelthos Therapeutics to Combine With Channel Therapeutics

THOMSON REUTERS
·
17 Apr

Channel Therapeutics Corp - Upon Completion of Deal, Plesha to Become CEO of Combined Co and Knuettel to Become CFO

THOMSON REUTERS
·
17 Apr

Channel Therapeutics Corp - Proposed Transaction Will Raise $50 Mln in Equity Capital

THOMSON REUTERS
·
17 Apr

Channel Therapeutics Corp -Combined Co to Operate Under Name Pelthos Therapeutics Inc., Trade on Nyse American Exchange Under Ticker Pths

THOMSON REUTERS
·
17 Apr

Channel Therapeutics Corp - Ligand Is Entitled to a 13% Royalty on Worldwide Sales of Zelsuvmi

THOMSON REUTERS
·
17 Apr

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

GlobeNewswire
·
17 Apr

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity

Benzinga
·
17 Apr

BUZZ-U.S. STOCKS ON THE MOVE-AppLovin, Ligand Pharma, Dexcom

Reuters
·
11 Apr

BUZZ-Stifel starts coverage on Ligand Pharma with 'buy'

Reuters
·
10 Apr

Ligand Pharmaceuticals Inc : Stifel Initiates Coverage With Buy Rating; Price Target $143

THOMSON REUTERS
·
10 Apr

Stifel Initiates Ligand Pharmaceuticals at Buy With $143 Price Target

MT Newswires Live
·
10 Apr

Ligand initiated with a Buy at Stifel

TIPRANKS
·
10 Apr

Ligand Pharmaceuticals FY 2024 GAAP EPS $(7.83) Misses $2.10 Estimate, Cash Balance Of $83.6M Expected To Fund Operations Into The Second Half Of 2027

Benzinga
·
31 Mar